The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated in a drug used to treat pulmonary fibrosis. The researchers show that these nanoparticles are highly capable of remaining trapped in the dise…

AI summaries can be wrong sometimes—always verify important details using the source article.